As of the latest SEC filings, Janux Therapeutics, Inc. (JANX) is held by 183 institutional funds. The largest fund shareholder is State Street(R) SPDR(R) S&P(R) Biotech ETF (XBI), holding an estimated $19,801,106.00 in market value, representing 0.27% of its portfolio.
Funds holding Janux Therapeutics, Inc. (JANX)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- JANX
- CIK:
- 0001817713
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.27% | $19,801,106.00 | 1,424,540 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $17,039,134.30 | 1,225,837 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.02% | $14,630,292.10 | 1,052,539 | Mar 31, 2026 | May 28, 2026 |
|
JAGLX
Janus Henderson Global Life Sciences Fund
|
MF | Independent / Boutique | 0.19% | $10,009,028.60 | 720,074 | Mar 31, 2026 | May 29, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $7,530,950.50 | 541,795 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.02% | $6,091,098.12 | 423,876 | Apr 30, 2026 | Jun 26, 2026 |
|
VSEQX
VANGUARD STRATEGIC EQUITY FUND
|
MF | Vanguard | 0.06% | $5,888,679.40 | 423,646 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.07% | $5,453,651.10 | 392,349 | Mar 31, 2026 | May 28, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.02% | $4,689,821.94 | 326,362 | Apr 30, 2026 | Jun 26, 2026 |
|
FBTIX
Fidelity Advisor Biotechnology Fund
|
MF | Fidelity | 0.24% | $4,603,932.45 | 320,385 | Apr 30, 2026 | Jun 26, 2026 |
|
QASCX
Federated Hermes MDT Small Cap Core Fund
|
MF | Federated Hermes | 0.23% | $4,284,961.56 | 298,188 | Apr 30, 2026 | Jun 23, 2026 |
|
FSSLX
Fidelity Series Small Cap Core Fund
|
MF | Fidelity | 0.25% | $4,078,206.00 | 283,800 | Apr 30, 2026 | Jun 26, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.01% | $4,010,404.26 | 294,666 | Feb 28, 2026 | Apr 24, 2026 |
|
BDSKX
BlackRock Advantage Small Cap Core Fund
|
MF | BlackRock / iShares | 0.08% | $3,560,090.19 | 261,579 | Feb 27, 2026 | Apr 24, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.03% | $3,421,318.20 | 246,138 | Mar 31, 2026 | May 28, 2026 |
|
FBCHX
Fidelity Blue Chip Growth Fund
|
MF | Fidelity | 0.00% | $3,316,222.38 | 230,774 | Apr 30, 2026 | Jun 26, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.02% | $3,171,647.18 | 233,038 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.02% | $2,893,635.71 | 212,611 | Feb 28, 2026 | Apr 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.05% | $2,812,778.70 | 206,670 | Feb 28, 2026 | Apr 24, 2026 |
|
FCTDX
Strategic Advisers Fidelity U.S. Total Stock Fund
|
MF | Fidelity | 0.00% | $2,756,025.00 | 202,500 | Feb 28, 2026 | Apr 24, 2026 |
|
QASGX
Federated Hermes MDT Small Cap Growth Fund
|
MF | Federated Hermes | 0.25% | $1,893,851.04 | 131,792 | Apr 30, 2026 | Jun 23, 2026 |
|
VSTCX
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND
|
MF | Vanguard | 0.07% | $1,647,038.80 | 118,492 | Mar 31, 2026 | May 28, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.01% | $1,612,747.50 | 116,025 | Mar 31, 2026 | May 28, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.01% | $1,607,735.69 | 118,129 | Feb 28, 2026 | Apr 28, 2026 |
|
SCSRX
Allspring Common Stock Fund
|
MF | Allspring | 0.28% | $1,593,940.80 | 114,672 | Mar 31, 2026 | May 27, 2026 |
Advertisement (320x50)